
Aflibercept was a less cost-effective treatment for retinal vein occlusion (RVO) compared with bevacizumab, although visual acuity outcomes were similar.
Aflibercept was a less cost-effective treatment for retinal vein occlusion (RVO) compared with bevacizumab, although visual acuity outcomes were similar.
Budd-Chiari syndrome and myeloproliferative neoplasms (MPNs) are rare, which means available data are limited.
The researchers of a new study highlighted the unique financial burden facing these patients, eligible for hematopoietic stem cell transplantation (HSCT), who often require lengthy hospitalizations and have associated risks of acute and chronic morbidity.
If approved by the FDA, sotatercept would be the first therapy that acts directly against the cause of the disease.
A panel of top practice administrators, moderated by Danielle Geiger, APRN-NP, of Nebraska Cancer Specialists, explored ways for practices to improve the bottom line at the Quality Cancer Care Alliance (QCCA) spring conference, held April 19-21, 2023.
Health systems participating in the drug discount program did not have fewer disparities than hospitals not participating.
UnitedHealthcare will require most colonoscopies to have prior authorization; the World Health Organization says that progress in reducing maternal and infant deaths has halted; hospitals are creating their own police forces to address increasing violence against staff.
A recent study compared hospitalizations and ages of children with respiratory syncytial virus (RSV) infection before the pandemic and afterwards.
Nicholas Bagley, JD, says immediate effects of the ruling have been modest so far.
Using a diverse human gut community, researchers investigated how gut microbiota interspecies interactions affected the response of Clostridioides difficile to vancomycin and metronidazole.
The best leaders are those who foster open communication, says Lee A. Norman, MD, MHS, MBA, who appeared at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event on population health in Kansas City, Missouri.
New study findings show this risk was higher among children born prematurely or whose mother was classified as having low socioeconomic status.
An analysis of an urban population of children indicated that age was a strong predictor in the diagnosis of respiratory syncytial virus (RSV) and influenza.
The Clostridioides difficile study was presented at Digestive Disease Week in Chicago.
Individuals living with heart failure in the United States are expected to top 8 million by 2030 vs the close to 6 million living with the disease between 2015 and 2018.
The study identified 3 themes related to diabetes self-care in patients who have type 1 diabetes (T1D), including emotional stress and anxiety and concerns regarding the COVID-19 pandemic.
At the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting, a patient joined a panel to give insight into the challenges of living with a chronic illness and what he sees as the pros and cons of the Inflation Reduction Act (IRA).
The patient had hemophilia A, but reported no trauma preceding the hematoma.
Elizabeth Johnson, LPN, PACS, BPCA, CEO of MedicoCX, co-CEO of Healthcare Advocate Summit, and an Asembia 2023 presenter, discusses why more empathetic approaches that take into account the full range of the patient experience are needed to improve patient-focused health care.
Despite similar health care utilization, White patients were much more likely to receive and fill prescriptions for medications to treat opioid use disorder (OUD) compared with Black or Hispanic patients in the months following a high-risk OUD event such as an overdose, a new study has found.
The results indicate that the program could play a role in discouraging use of biosimilars in the United States.
The training did not, however, affect postoperative limb skeletal muscle weakness or exercise capacity.
Researchers compared chimeric antigen receptor T-cell therapies axicabtagene ciloleucel (axi-cel) and tisagenlecleucel.
Chronic obstructive pulmonary disease (COPD) exacerbations and oral corticosteroid use dropped in patients treated with monoclonal antibodies targeting interleukin (IL)-5 and its receptor (IL-5R), a study found.
Panelists from Optum Life Sciences, OptumRx, and Takeda discussed the importance of collaboration in creating successful value-based agreements (VBAs) at Asembia 2023.
The American Journal of Managed Care® interviewed 2 presenters at Asembia 2023, gaining insight on how the specialty pharmacy pipeline is growing and how health systems and payers can affect the accessibility and affordability of new specialty therapies.
The FDAs newest blood donation guidance may expand donation eligibility; Pfizer CEO anticipates lawsuits to stop US drug price plan; drug shortages have worsened and may increase even with the end of the COVID-19 public health emergency.
The Dario Diabetes Solution app was developed to help better manage type 2 diabetes.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Jessica Robinson-Papp, MD, MS, professor of neurology at the Icahn School of Medicine at Mount Sinai, talks about the strides made in antiretroviral therapy for HIV and how these improvements lead to better patient outcomes.
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.